Douglas Gregory

1.0k total citations
23 papers, 525 citations indexed

About

Douglas Gregory is a scholar working on Cardiology and Cardiovascular Medicine, Economics and Econometrics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Douglas Gregory has authored 23 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 6 papers in Economics and Econometrics and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Douglas Gregory's work include Heart Failure Treatment and Management (13 papers), Cardiac pacing and defibrillation studies (4 papers) and Healthcare Policy and Management (4 papers). Douglas Gregory is often cited by papers focused on Heart Failure Treatment and Management (13 papers), Cardiac pacing and defibrillation studies (4 papers) and Healthcare Policy and Management (4 papers). Douglas Gregory collaborates with scholars based in United States, France and Israel. Douglas Gregory's co-authors include Marvin A. Konstam, Kathleen C. Perry, Ira B. Wilson, Walter Baigelman, Andrew Weintraub, Ayan R. Patel, David Venesy, Daniel Levine, James E. Udelson and Joseph M. Massaro and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Medicine and American Heart Journal.

In The Last Decade

Douglas Gregory

23 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Douglas Gregory United States 12 309 95 76 71 63 23 525
Jean‐Pierre Villemot France 13 469 1.5× 196 2.1× 20 0.3× 69 1.0× 51 0.8× 31 716
Víctor Gil Portugal 14 371 1.2× 114 1.2× 30 0.4× 11 0.2× 93 1.5× 81 690
B.J. Gersh United States 11 394 1.3× 264 2.8× 32 0.4× 25 0.4× 35 0.6× 31 614
Darshan H. Brahmbhatt Canada 12 175 0.6× 76 0.8× 40 0.5× 30 0.4× 24 0.4× 35 380
Frances Wright United Kingdom 8 254 0.8× 102 1.1× 55 0.7× 6 0.1× 86 1.4× 10 610
L. Mandelzweig Israel 6 472 1.5× 143 1.5× 32 0.4× 9 0.1× 41 0.7× 7 603
Juan Carlos Zevallos United States 14 205 0.7× 46 0.5× 20 0.3× 36 0.5× 119 1.9× 36 500
Marcin Sadowski Poland 14 418 1.4× 201 2.1× 23 0.3× 11 0.2× 66 1.0× 87 692
Margarida Borges Portugal 13 151 0.5× 71 0.7× 31 0.4× 9 0.1× 88 1.4× 49 474
J.-P. Cambou France 10 208 0.7× 146 1.5× 39 0.5× 10 0.1× 47 0.7× 30 413

Countries citing papers authored by Douglas Gregory

Since Specialization
Citations

This map shows the geographic impact of Douglas Gregory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Gregory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Gregory more than expected).

Fields of papers citing papers by Douglas Gregory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Gregory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Gregory. The network helps show where Douglas Gregory may publish in the future.

Co-authorship network of co-authors of Douglas Gregory

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Gregory. A scholar is included among the top collaborators of Douglas Gregory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Gregory. Douglas Gregory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Mills, Russell W., et al.. (2022). Guide to Evaluating Airport Governance Structures. Transportation Research Board eBooks. 2 indexed citations
3.
Anand, Inder S., Jeffrey L. Ardell, Douglas Gregory, et al.. (2020). EFFECTS OF SYMPATHETIC BLOCKADE ON RESPONSIVENESS TO VNS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION. Journal of the American College of Cardiology. 75(11). 780–780. 2 indexed citations
4.
Klein, Liviu, Barry Greenberg, Marvin A. Konstam, et al.. (2015). Activities and Compensation of Advanced Heart Failure Specialists: Results of the Heart Failure Society of America (HFSA) Survey. Journal of Cardiac Failure. 21(11). 924–929. 1 indexed citations
5.
Kiernan, Matthew C., Douglas Gregory, Patrick Rossignol, et al.. (2015). Early and Late Effects of High- Versus Low-Dose Angiotensin Receptor Blockade on Renal Function and Outcomes in Patients With Chronic Heart Failure. JACC Heart Failure. 3(3). 214–223. 16 indexed citations
6.
Rossignol, Patrick, Nicolas Girerd, Douglas Gregory, et al.. (2015). Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study. International Journal of Cardiology. 187. 183–189. 25 indexed citations
7.
Rossignol, Patrick, Daniela Dobre, Douglas Gregory, et al.. (2014). Incident hyperkalemia may be an independent therapeutic target in low ejection fraction heart failure patients: Insights from the HEAAL study. International Journal of Cardiology. 173(3). 380–387. 25 indexed citations
8.
Kiernan, Michael S., Patrick Rossignol, Mark J. Sarnak, et al.. (2012). EARLY AND LATE EFFECTS OF ANGIOTENSIN RECEPTOR BLOCKADE ON KIDNEY FUNCTION IN PATIENTS WITH CHRONIC HEART FAILURE. Journal of the American College of Cardiology. 59(13). E1040–E1040. 1 indexed citations
9.
Quyyumi, Arshed A., Edmund K. Waller, Jonathan R. Murrow, et al.. (2010). CD34+ cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal. 161(1). 98–105. 119 indexed citations
10.
Weintraub, Andrew, Douglas Gregory, Ayan R. Patel, et al.. (2010). A Multicenter Randomized Controlled Evaluation of Automated Home Monitoring and Telephonic Disease Management in Patients Recently Hospitalized for Congestive Heart Failure: The SPAN-CHF II Trial. Journal of Cardiac Failure. 16(4). 285–292. 68 indexed citations
11.
12.
Gregory, Douglas, et al.. (2009). A Cost-Saving Strategy for Inpatient Management of Advanced Decompensated Heart Failure Patients: The Cardiomyopathy Unit. Journal of Cardiac Failure. 15(5). 428–434. 3 indexed citations
13.
Hauptman, Paul J., Michael W. Rich, Paul A. Heidenreich, et al.. (2008). The Heart Failure Clinic: A Consensus Statement of the Heart Failure Society of America. Journal of Cardiac Failure. 14(10). 801–815. 65 indexed citations
14.
Gregory, Douglas, Carey Kimmelstiel, Kathleen C. Perry, et al.. (2006). Hospital cost effect of a heart failure disease management program: The Specialized Primary and Networked Care in Heart Failure (SPAN-CHF) trial. American Heart Journal. 151(5). 1013–1018. 28 indexed citations
15.
Gregory, Douglas, David DeNofrio, & Marvin A. Konstam. (2005). The Economic Effect of a Tertiary Hospital-Based Heart Failure Program. Journal of the American College of Cardiology. 46(4). 660–666. 5 indexed citations
16.
Weintraub, Andrew, Carey Kimmelstiel, Danielle Levine, et al.. (2005). A Multicenter Randomized Controlled Comparison of Telephonic Disease Management vs. Automated Home Monitoring in Patients Recently Hospitalized with Heart Failure: Span-CHF II Trial. Journal of Cardiac Failure. 11(9). 720–720. 11 indexed citations
17.
Gregory, Douglas, Walter Baigelman, & Ira B. Wilson. (2003). Hospital Economics of the Hospitalist. Health Services Research. 38(3). 905–918. 49 indexed citations
18.
Havranek, Edward P., Harlan M. Krumholz, R. Adams Dudley, et al.. (2003). Aligning quality and payment for heart failure care: Defining the challenges. Journal of Cardiac Failure. 9(4). 251–254. 7 indexed citations
19.
Gregory, Douglas, James E. Udelson, & Marvin A. Konstam. (2001). Economic impact of beta blockade in heart failure. The American Journal of Medicine. 110(7). 74–80. 24 indexed citations
20.
Gregory, Douglas, et al.. (1981). Feasibility of an alcoholism health insurance benefit.. PubMed. 8. 195–202. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean‐Pierre Villemot Breakdown of academic impact, for papers by Víctor Gil Breakdown of academic impact, for papers by B.J. Gersh Breakdown of academic impact, for papers by Darshan H. Brahmbhatt Breakdown of academic impact, for papers by Frances Wright Breakdown of academic impact, for papers by L. Mandelzweig Breakdown of academic impact, for papers by Juan Carlos Zevallos Breakdown of academic impact, for papers by Marcin Sadowski Breakdown of academic impact, for papers by Margarida Borges Breakdown of academic impact, for papers by J.-P. Cambou
Rankless by CCL
2026